| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.45 | 0.003 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.34 | 0.006 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.007 |